These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1399515)

  • 1. Increase in frequency of serious group A streptococcal infections.
    Rudensky B; Isaacson M; Beck A; Greenfield J
    Isr J Med Sci; 1992 Oct; 28(10):752-3. PubMed ID: 1399515
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona].
    Viñado B; Domínguez J; Rodrigo C; Matas L
    Med Clin (Barc); 1999 Apr; 112(14):556. PubMed ID: 10363246
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resistance to macrolides in Streptococcus pyogenes].
    Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
    Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythromycin-resistant Streptococcus pyogenes in Argentina.
    Lopardo HA; Hernandez C; Vidal P; Vazquez M; Rosaenz L; Rubinstein G; Smayevsky J; Tokumoto M; Fernandez Lausi A; Daher O; Kaufman S; Soriano SV; Brasili S; Bottiglieri M; Carranza MC
    Medicina (B Aires); 2004; 64(2):143-5. PubMed ID: 15628302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leg ulcer infection with an erythromycin-resistant Streptococcus pyogenes.
    Hardie R; Hardie RA
    Scott Med J; 1986 Jan; 31(1):39. PubMed ID: 3515552
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of streptococcal infections: implications of antimicrobial drug resistance in Streptococcus pyogenes.
    Hansman D
    Med J Aust; 1989 Jun; 150(11):611-2. PubMed ID: 2657346
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence and characteristics of Streptococcus pyogenes resistant to lincomycin and erythromycin.
    Dixon JM; Lipinski AE
    J Med Microbiol; 1973 May; 6(2):Pxv. PubMed ID: 4575282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Streptococcal pharyngitis: epidemiological and therapeutic aspects (sensitivity to antibioticotherapy)].
    Fanini A; Vignola D; Pasqualini M; Bellaz M
    Clin Ter; 1983 May; 105(4):317-22. PubMed ID: 6347502
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic implications of erythromycin resistance in group A streptococci.
    Coonan K; Kaplan EL
    Pediatr Infect Dis J; 1993 Mar; 12(3):261-2. PubMed ID: 8451111
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan.
    Hsueh PR; Shyr JM; Wu JJ
    Clin Infect Dis; 2005 Mar; 40(6):903-5. PubMed ID: 15736030
    [No Abstract]   [Full Text] [Related]  

  • 14. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
    Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
    Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythromycin resistance in Finland declines after reduction in macrolide use.
    Am J Health Syst Pharm; 1997 Nov; 54(21):2436-7. PubMed ID: 9359947
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
    Gagliotti C; Nobilio L; Milandri M; Moro ML;
    Clin Infect Dis; 2006 Apr; 42(8):1153-6. PubMed ID: 16575736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.
    Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K
    Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
    Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
    Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross resistance between lincomycin and erythromycin in viridans streptococci.
    Sprunt K; Leidy G; Redman W
    Pediatrics; 1970 Jul; 46(1):84-8. PubMed ID: 5423461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.